Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents

被引：0
|
作者：
Giuseppe Biondi-Zoccai
Cristian M. Garmendia
Antonio Abbate
Arturo Giordano
Giacomo Frati
Sebastiano Sciarretta
Barbara Antonazzo
Francesco Versaci
机构：
[1] Sapienza University of Rome,Department of Medico
[2] Mediterranea Cardiocentro,Surgical Sciences and Biotechnologies
[3] Virginia Commonwealth University,Pauley Heart Center, Department of Internal Medicine
[4] Presidio Ospedaliero Pineta Grande,Unità Operativa di Interventistica Cardiovascolare
[5] IRCCS NEUROMED,Division of Geriatrics
[6] Israelite Hospital,Unità Operativa Complessa di Cardiologia
[7] Ospedale Santa Maria Goretti,undefined
来源：
Current Atherosclerosis Reports | 2020年 / 22卷
关键词：
Anakinra; Anti-interleukin-1 agent; Atherosclerosis; Atherothrombosis; Canakinumab; Heart failure; Interleukin-1; Peripheral artery disease; Stroke;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Dose-Response Profile of a Novel Anti-Interleukin-1 Therapeutic, Rytvela, for Prevention of Preterm Birth.
    Habelrih, Tiffany
    Loiselle, Sarah-Eve
    Cote, France
    Hou, Xin
    Quiniou, Christiane
    Chemtob, Sylvain
    [J]. REPRODUCTIVE SCIENCES, 2021, 28 (SUPPL 1) : 58A - 59A
  • [22] The anti-interleukin-1 in type 1 diabetes action trial - background and rationale
    Pickersgill, Linda M. S.
    Mandrup-Poulsen, Thomas R.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (04) : 321 - 324
  • [23] Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis
    Kloppenburg, Margreet
    Peterfy, Charles
    Haugen, Ida K.
    Kroon, Feline
    Chen, Su
    Wang, Li
    Liu, Wei
    Levy, Gwen
    Fleischmann, Roy M.
    Berenbaum, Francis
    van der Heijde, Desiree
    Bansal, Prashant
    Wittoek, Ruth
    Feng, Sheng
    Fang, Yuni
    Saltarelli, Mary
    Medema, Jeroen K.
    Levesque, Marc C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (03) : 413 - 420
  • [24] Efficacy and safety profile of anti-interleukin-1 treatment in Behcet's disease: a multicenter retrospective study
    Emmi, Giacomo
    Talarico, Rosaria
    Lopalco, Giuseppe
    Cimaz, Rolando
    Cantini, Fabrizio
    Viapiana, Ombretta
    Olivieri, Ignazio
    Goldoni, Matteo
    Vitale, Antonio
    Silvestri, Elena
    Prisco, Domenico
    Lapadula, Giovanni
    Galeazzi, Mauro
    Iannone, Florenzo
    Cantarini, Luca
    [J]. CLINICAL RHEUMATOLOGY, 2016, 35 (05) : 1281 - 1286
  • [25] Efficacy of anti-interleukin-1 treatment in colchicine-resistant arthritis in patients with familial Mediterranean fever
    Kehribar, Demet Yalcin
    Ozgen, Metin
    [J]. EUROPEAN JOURNAL OF RHEUMATOLOGY, 2021, 8 (01) : 16 - 19
  • [26] Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis
    Sargin, Gokhan
    Kose, Reyhan
    Senturk, Taskin
    [J]. SAO PAULO MEDICAL JOURNAL, 2019, 137 (01): : 39 - 44
  • [27] Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab
    Sanz, Pablo Lopez
    Perez, Marta Guzman
    Defez, Jose Manuel Azana
    Ramirez, Claudia Guerrero
    Cordoba, Silvia Manso
    Martinez, Maria Encarnacion Alfaro
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (05) : 535 - 536
  • [28] Anti-interleukin 1 agents for the treatment of recurrent pericarditis
    Imazio, M.
    Andreis, A.
    Piroli, F.
    Lazaros, G.
    Lewinter, M.
    Klein, A.
    Brucato, A.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1829 - 1829
  • [29] EFFECT OF ANTI-INTERLEUKIN-1 ADMINISTRATION TO RATS WITH ADRIAMYCIN-INDUCED NEPHROSIS
    BRICIO, T
    MOLINA, A
    MAMPASO, F
    [J]. APMIS, 1992, 100 (05) : 401 - 407
  • [30] Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
    Abhijit Chakraborty
    Stacey Tannenbaum
    Christiane Rordorf
    Philip J. Lowe
    David Floch
    Hermann Gram
    Sandip Roy
    [J]. Clinical Pharmacokinetics, 2012, 51 (6) : e1 - e18
12345